Option Care Health (NASDAQ:OPCH) Price Target Raised to $40.00

Option Care Health (NASDAQ:OPCH) had its price target upped by JPMorgan Chase & Co. from $38.00 to $40.00 in a research report released on Friday,Benzinga reports. They currently have an overweight rating on the stock.

Several other analysts also recently issued reports on OPCH. UBS Group initiated coverage on shares of Option Care Health in a research report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price target for the company. The Goldman Sachs Group downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and reduced their price target for the company from $38.00 to $27.00 in a research report on Monday, November 4th. Barrington Research lifted their price objective on shares of Option Care Health from $32.00 to $33.00 and gave the stock an “outperform” rating in a report on Tuesday, January 14th. Truist Financial cut their price objective on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Finally, Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $26.00 to $35.00 in a report on Thursday. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $32.25.

Option Care Health Stock Performance

NASDAQ:OPCH opened at $30.33 on Friday. The company has a fifty day moving average of $24.42 and a 200-day moving average of $27.83. The firm has a market capitalization of $5.16 billion, a P/E ratio of 25.49, a P/E/G ratio of 2.11 and a beta of 1.31. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health has a twelve month low of $21.39 and a twelve month high of $34.63.

Insider Activity at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the firm’s stock in a transaction dated Friday, November 8th. The shares were purchased at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the transaction, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. This represents a 15.18 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. 0.64% of the stock is currently owned by company insiders.

Institutional Trading of Option Care Health

Several hedge funds and other institutional investors have recently bought and sold shares of the company. UMB Bank n.a. boosted its stake in shares of Option Care Health by 937.5% during the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock valued at $26,000 after purchasing an additional 750 shares during the period. GAMMA Investing LLC boosted its stake in shares of Option Care Health by 110.6% during the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after purchasing an additional 471 shares during the period. Whittier Trust Co. of Nevada Inc. boosted its stake in shares of Option Care Health by 3,362.8% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock valued at $47,000 after purchasing an additional 1,446 shares during the period. International Assets Investment Management LLC raised its holdings in shares of Option Care Health by 3,029.7% during the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock valued at $91,000 after acquiring an additional 2,757 shares in the last quarter. Finally, Quarry LP raised its holdings in shares of Option Care Health by 327.7% during the third quarter. Quarry LP now owns 3,430 shares of the company’s stock valued at $107,000 after acquiring an additional 2,628 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.